Would you learn another fine injection technique to access a patient population of 30 million? This week, AmSpa founder and CEO, Alex R. Thiersch, JD, speaks with Keetha Hanlin, RN, LME, senior clinical advisor at Methapharm, distributor of sclerosing agent Asclera. Drawing on her 20 years of experience, Hanlin discusses sclerotherapy as a treatment for spider and reticular veins in the lower extremity, and how to incorporate cosmetic vein treatment in your aesthetic practice. Listen to hear more about:
- Sclerotherapy vs. laser for spider and reticular veins;
- The “HASTI” algorithm process to screen patient candidates;
- Partnering with specialists to treat underlying venous disease;
- Potential complications of sclerotherapy and how to avoid them;
- How to package sclerotherapy with your membership program;
- When to inject, profitability, hands-on training, and more!
---
Music By Ghost Score
Would you learn another fine injection technique to access a patient population of 30 million? This week, AmSpa founder and CEO, Alex R. Thiersch, JD, speaks with Keetha Hanlin, RN, LME, senior clinical advisor at Methapharm, distributor of sclerosing agent Asclera. Drawing on her 20 years of experience, Hanlin discusses sclerotherapy as a treatment for spider and reticular veins in the lower extremity, and how to incorporate cosmetic vein treatment in your aesthetic practice. Listen to hear more about:
Sclerotherapy vs. laser for spider and reticular veins;
The “HASTI” algorithm process to screen patient candidates;
Partnering with specialists to treat underlying venous disease;
Potential complications of sclerotherapy and how to avoid them;
How to package sclerotherapy with your membership program;
When to inject, profitability, hands-on training, and more!
---
Music By Ghost Score
